期刊文献+

神经胶质瘤中细胞增殖核抗原Ki-67的表达及研究

A Study and Expression of the Ki-67 Proliferation Nuclear Antigen in Gliomas
下载PDF
导出
摘要 目的探讨神经胶质瘤组织中Ki-67抗原表达及其与肿瘤发生和恶性程度的关系。方法应用免疫组化Envision法对39例颅内神经胶质细胞瘤标本中Ki-67抗原的表达进行检测,观察Ki-67与神经肿瘤恶性程度间的关系。结果不同恶性程度胶质细胞瘤间Ki-67表达强度有明显差异(F=36.375,P<0.05),与肿瘤的恶性程度呈正相关(r=0.939,P<0.05)。结论细胞增殖核抗原Ki-67的表达与胶质瘤的发生及其恶性程度有一定关系,临床检测Ki-67指数有助于患者预后评估。 Objective To explore the Ki-67 expression in human gliomas and its implication to tumorigenesis and the degree of gliomas' malignancy. Methods After Ki-67 antigen expression in 39 gliomas were determined hy immunohistochemica] technique, we evaluate the relation Ki-67 expression and the one between the degree of gliomas' malignancy. Results The expression of ki-67 antigen were significantly different (P〈36.375, P〈0.05), and had a positive correlation with the malignant degrees (r=0.939, P〈0. 050). Conclusions The expression Ki-67 antigen could be related to the tumorigenesis and the degrees of malignancy of human brain gliomas. The Ki-67 L1 detected will provide more useful infonmation for patient's prognosis.
出处 《国际医药卫生导报》 2005年第16期13-14,共2页 International Medicine and Health Guidance News
关键词 神经胶质瘤 KI-67 免疫组织化学 Gliomas Ki-67 Immunohistochemical
  • 相关文献

参考文献8

二级参考文献26

  • 1史玉泉.实用神经病学(第2版)[M].上海:上海科学技术出版社,1994.736.
  • 2范郎娣.王德延肿瘤的病理诊断学(第2版)下册[M].天津:天津科学技术出版社,1999.1613-1701.
  • 3张玉林.对神经系统肿瘤的国际分类的新观点[J].中国临床神经科学,2001,9:105-108.
  • 4Dichamp C, Taillibert S, Aguirre-Cruz L, et al. Loss of 14q chromosome in oligodendroglial and astrocyfic tumors. J Neurooncol.2004 ,67(3) :281-285.
  • 5Felsberg J, Erkwoh A, Sabel MC, et al. Oligodendroglial tumors:refinement of candidale regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol. 2004 ,14(2):121-130.
  • 6Debiec - Rychter M, Birnat W, Zakrzewski K, et al.Loss of chromosome 22 and proliferative potential in epondymomas.Folia Neuropathol. 2003,41(4) :191-195.
  • 7Jung HL, Wang KC, Kim SK, et al. Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas. J Nourouncol. 2004 ,67(1-2) :41-46.
  • 8Lindsey JC, Lusher ME, Anderton JA, et al.Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.Carcinogenesis.2004,25 (5) : 661-668.Epub 2003 Dec 19.
  • 9Alonso ME, Bello MJ, Gonzalez-Gomez P, et al. Aberrant CpG island methylation of multiple genes in ependymal tumor. J Neurooncol. 2004,67(1-2) : 159-165.
  • 10Cohen N, Betts DR, Tavori U, et al. Karyotypic evolution pathways in medidloblastoma/primitive neuroectodermal tumor determined with a combination of spe ctral karyotyping, G-banding,and fluorescence in situ hybridization. Cancer Genet Cytogenet.2004,149(1):44-52.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部